VVP
GSK icon

Venture Visionary Partners’s GSK GSK Stock Holding History

Venture Visionary Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$260K Buy
5,407
+323
+6% +$16.5K 0.01% 599
2026
Q2 		$267K Buy
5,084
+66
+1% +$3.49K 0.01% 606
2026
Q1 		$277K Buy
+5,018
New +$272K 0.01% 532
2025
Q4 		– Sell
-5,398
Closed -$233K – 676
2025
Q3 		$233K Buy
5,398
+79
+1% +$3.09K 0.01% 558
2025
Q2 		$204K Sell
5,319
-284
-5% -$10.9K 0.01% 567
2025
Q1 		$217K Buy
+5,603
New +$205K 0.01% 522
2024
Q4 		– Sell
-5,880
Closed -$240K – 562
2024
Q3 		$240K Sell
5,880
-300
-5% -$12.3K 0.01% 493
2024
Q2 		$238K Sell
6,180
-230
-4% -$9.68K 0.01% 496
2024
Q1 		$275K Buy
6,410
+800
+14% +$33K 0.01% 467
2023
Q4 		$208K Sell
5,610
-143
-2% -$5.13K 0.01% 483
2023
Q3 		$209K Buy
+5,753
New +$204K 0.01% 464
2022
Q3 		– Sell
-5,384
Closed -$293K – 903
2022
Q2 		$293K Sell
5,384
-518
-9% -$28.6K 0.02% 384
2022
Q1 		$321K Buy
5,902
+492
+9% +$26.7K 0.02% 396
2021
Q4 		$324K Sell
5,410
-200
-4% -$10.4K 0.02% 394
2021
Q3 		$267K Sell
5,610
-48
-0.8% -$2.41K 0.02% 423
2021
Q2 		$281K Sell
5,658
-3,211
-36% -$154K 0.02% 402
2021
Q1 		$395K Buy
8,869
+1,037
+13% +$47.1K 0.03% 331
2020
Q4 		$360K Buy
+7,832
New +$360K 0.04% 285

Other funds holding GSK

KFP
Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return
BE
Bonness Enterprises Washington, District of Columbia $307M AUM 22.88% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
PC
Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return
BCM
Boltwood Capital Management Walnut Creek, California $443M AUM 17.72% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return

Venture Visionary Partners's GSK Position: Q3 2026 in Review

Venture Visionary Partners increased its GSK (GSK) stake by 6.4% in Q3 2026, buying an estimated $16.5K and bringing the position to 5,407 shares worth $260K. The position accounts for 0.01% of the portfolio, ranked #599.

Venture Visionary Partners first reported a position in GSK in Q4 2020 and has held it in 18 quarters since. The position peaked at $395K in Q1 2021. 33 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Venture Visionary Partners held 5,407 shares of GSK worth $260K as of Q3 2026.
  • Venture Visionary Partners bought 323 GSK shares in Q3 2026, an estimated $16.5K.
  • GSK made up 0.01% of Venture Visionary Partners's portfolio in Q3 2026, its #599 holding.
  • Venture Visionary Partners first reported a position in GSK in Q4 2020 and has held it in 18 quarters since.
  • Venture Visionary Partners's GSK position peaked at $395K in Q1 2021.
  • 33 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Venture Visionary Partners's 13F filing for Q3 2026, filed 7 Oct 2026.